Prevalence of Lung Cancer with a History of Tuberculosis
Downloads
Introduction: Lung cancer ranks as the second most common diagnosis of malignancy cases in the world with the highest mortality, while Indonesia is the country with the largest tuberculosis (TB) burden after India. Although these two diseases have a high incidence and mortality rate and are one of the main causes of health problems, coexistence between these two diseases is very rare. A similar clinical and radiological feature complicates the diagnosis and worsens the prognosis. This study aimed to determine the prevalence and distribution patterns of lung cancer incidence with a history of TB.
Methods: This was a descriptive study. The data were obtained retrospectively from the electronic medical records of lung cancer patients from one roof oncology clinic, Dr. Soetomo General Hospital, Surabaya, in 2018–2020, meeting the inclusion and exclusion criteria.
Results: Specifically, 76 out of 1,044 (7.3%) lung cancer patients had a history of TB, with the distribution being men (71.1%), in an age range of 50-59 years old (34.2%), who were active smokers (36.9%), had an adenocarcinoma type of cancer (90.8%), had a positive EGFR gene mutation (50%), and had a diagnosis of non–small cell lung cancer (NSCLC) during stage IV (79%) after a TB diagnosis (54%) with a time interval of 1 or >10 years.
Conclusion: The prevalence of lung cancer with a history of TB was 7.3%. Lung cancer screening is important in TB patients after one or even >10 years of diagnosis to reduce the morbidity and mortality rates because of this risk of coexistence.
(CDC) C for DC and P. What is Lung Cancer? CDC, https://www.cdc.gov/cancer/lung/basic_info/what-is-lung-cancer.htm (2021, accessed 27 June 2021).
Cukic V. The Association between Lung Carcinoma and Tuberculosis. Med Arch (Sarajevo, Bosnia Herzegovina) 2017; 71: 212–214.
Cancer IA for R on. Cancer Fact Sheets Indonesia Population. Geneva, https://gco.iarc.fr/today/data/factsheets/populations/360-indonesia-fact-sheets.pdf (2020).
World Health Organization (WHO). Global Tuberculosis Report 2022. Geneva, https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2022 (2022).
Dacosta NA, Kinare SG. Association of Lung Carcinoma and Tuberculosis. J Postgrad Med 1991; 37: 185–189.
CicÄ—nas S, VenceviÄius V. Lung Cancer in Patients with Tuberculosis. World J Surg Oncol 2007; 5: 22.
Ho JC-M, Leung C-C. Management of Co-Existent Tuberculosis and Lung Cancer. Lung Cancer 2018; 122: 83–87.
Çakar B, Çiledağ A. Evaluation of Coexistence of Cancer and Active Tuberculosis; 16 Case Aeries. Respir Med Case Reports 2018; 23: 33–37.
Nugroho NP, Wati FF. Koeksistensi Kanker Paru dan Tuberkulosis. Syifa' Med J Kedokt dan Kesehat; 11. Epub ahead of print 30 September 2020.
Suzuki Y, Imokawa S, Sato J, et al. Cumulative Incidence of Tuberculosis in Lung Cancer Patients in Japan: A 6-Year Observational Study. Respir Investig 2016; 54: 179–183.
Christopoulos A, Saif MW, Sarris EG, et al. Epidemiology of Active Tuberculosis in Lung Cancer Patients: A Systematic Review. Clin Respir J 2014; 8: 375–381.
Sholih MG, Perwitasari DA, Hendriani R, et al. Risk Factors of Lung Cancer in Indonesia: A Qualitative Study. J Adv Pharm Educ Res 2019; 9: 41–45.
Silva DR, Valentini Junior DF, Müller AM, et al. Pulmonary Tuberculosis and Lung Cancer: Simultaneous and Sequential Occurrence. Jornal Brasileiro de Pneumologia; 39.
Watanabe A, Tokue Y, Takahashi H, et al. [Management of Mycobacteriosis in General Hospital without Isolation Ward for Tuberculosis Patients. Clinical Study on Pulmonary Tuberculosis associated with Lung Cancer Patients]. Kekkaku 1999; 74: 157–162.
An SJ, Kim Y-J, Han S-S, et al. Effects of Age on the Association between Pulmonary Tuberculosis and Lung Cancer in a South Korean Cohort. J Thorac Dis Vol 12, No 3 (March 23, 2020) J Thorac Dis, https://jtd.amegroups.com/article/view/36109 (2020).
Qin Y, Chen Y, Chen J, et al. The Relationship between Previous Pulmonary Tuberculosis and Risk of Lung Cancer in the Future. Infect Agent Cancer 2022; 17: 20.
Wu C-Y, Hu H-Y, Pu C-Y, et al. Pulmonary Tuberculosis increases the Risk of Lung Cancer. Cancer 2011; 117: 618–624.
Oh C-M, Roh Y-H, Lim D, et al. Pulmonary Tuberculosis is Associated with Elevated Risk of Lung cancer in Korea: The Nationwide Cohort Study. J Cancer 2020; 11: 1899–1906.
Molina-Romero C, Arrieta O, Hernández-Pando R. Tuberculosis and Lung Cancer. Salud Publica Mex 2019; 61: 286–291.
Rihawi A, Huang G, Al-Hajj A, et al. A Case of Tuberculosis and Adenocarcinoma Coexisting in the Same Lung Lobe. Int J Mycobacteriology 2016; 5: 80–82.
Hwang IK, Paik SS, Lee SH. Impact of Pulmonary Tuberculosis on the EGFR Mutational Status and Clinical Outcome in Patients with Lung Adenocarcinoma. Cancer Res Treat 2019; 51: 158–168.
Jin C, Yang B. A Case of Delayed Diagnostic Pulmonary Tuberculosis during Targeted Therapy in an EGFR Mutant Non-Small Cell Lung Cancer Patient. Case Reports in Oncology 2021; 14: 659–663.
Byun HG, Yoo JY, Kim SJ, et al. Coexistence of Lung Adenocarcinoma and Pulmonary Tuberculosis within a Single Lesion: A Rare Case Report. Medicine (Baltimore) 2019; 98: e17378.
Parker CS, Siracuse CG, Litle VR. Identifying Lung Cancer in Patients with Active Pulmonary Tuberculosis. J Thorac Dis Vol 10, Suppl 28 (October 19, 2018) J Thorac Dis (Medical Surg Manag Pulm Infect, https://jtd.amegroups.com/article/view/22911 (2018).
Copyright (c) 2023 Nadira Putri Nastiti, Laksmi Wulandari, Sulistiawati Sulistiawati, Anna Febriani, Wiwin Is Effendi
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions.
3. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution Share-Alike (CC BY-SA).
4. The Creative Commons Attribution Share-Alike (CC BY-SA) license allows re-distribution and re-use of a licensed work on the conditions that the creator is appropriately credited and that any derivative work is made available under "the same, similar or a compatible license”. Other than the conditions mentioned above, the editorial board is not responsible for copyright violation.